{"id":150413,"date":"2025-12-13T10:14:35","date_gmt":"2025-12-13T03:14:35","guid":{"rendered":"https:\/\/hmm88i.com\/drug\/?post_type=product&p=150413"},"modified":"2025-12-13T10:16:49","modified_gmt":"2025-12-13T03:16:49","slug":"easyef-0-5-mg-ml","status":"publish","type":"product","link":"https:\/\/hmm88i.com\/drug\/easyef-0-5-mg-ml\/","title":{"rendered":"Easyef 0.5 mg\/ml"},"content":{"rendered":"

Trong b\u00e0i vi\u1ebft n\u00e0y, <\/strong>d\u01b0\u1ee3c s\u0129 L\u01b0u V\u0103n Ho\u00e0ng<\/strong><\/a> gi\u1edbi thi\u1ec7u \u0111\u1ebfn c\u00e1c b\u1ea1n s\u1ea3n ph\u1ea9m thu\u1ed1c Easyef 0.5 mg\/ml<\/a> \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi DaewoongPharmaceutical Co., Ltd., c\u00f3 s\u1ed1 \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh t\u1ea1i Vi\u1ec7t Nam l\u00e0 880410324325 (S\u0110K c\u0169: QLSP-860-15).<\/strong><\/p>\n

Easyef 0.5 mg\/ml l\u00e0 thu\u1ed1c g\u00ec?<\/h2>\n

Th\u00e0nh ph\u1ea7n<\/h3>\n

Thu\u1ed1c Easyef 0.5 mg\/ml<\/strong> c\u00f3 ch\u1ee9a th\u00e0nh ph\u1ea7n: Nepidermin 0,5mg\/ml<\/p>\n

D\u1ea1ng b\u00e0o ch\u1ebf: Dung d\u1ecbch phun x\u1ecbt tr\u00ean da<\/p>\n

Tr\u00ecnh b\u00e0y<\/h3>\n

S\u0110K: 880410324325 (S\u0110K c\u0169: QLSP-860-15)<\/p>\n

Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p 1 b\u1ed9 10ml (b\u01a1m ti\u00eam ch\u1ee9a 1ml dung d\u1ecbch thu\u1ed1c + l\u1ecd ch\u1ee9a 9ml dung m\u00f4i)<\/p>\n

Xu\u1ea5t x\u1ee9: H\u00e0n Qu\u1ed1c<\/p>\n

H\u1ea1n s\u1eed d\u1ee5ng: 24 th\u00e1ng<\/p>\n

T\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Easyef 0.5 mg\/ml<\/h2>\n

C\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/h3>\n

Nepidermin \u0111\u00f3ng vai tr\u00f2 quan tr\u1ecdng trong vi\u1ec7c t\u0103ng tr\u01b0\u1edfng t\u1ef1 nhi\u00ean c\u1ee7a c\u01a1 th\u1ec3 ng\u01b0\u1eddi, th\u00fac \u0111\u1ea9y qu\u00e1 tr\u00ecnh t\u00e1i t\u1ea1o m\u00f4 v\u00e0 l\u00e0m l\u00e0nh v\u1ebft th\u01b0\u01a1ng. Ho\u1ea1t ch\u1ea5t c\u00f3 c\u1ea5u tr\u00fac v\u00e0 ho\u1ea1t t\u00ednh sinh h\u1ecdc t\u01b0\u01a1ng t\u1ef1 EGF t\u1ef1 nhi\u00ean, li\u00ean k\u1ebft v\u1edbi th\u1ee5 th\u1ec3 EGFR n\u1eb1m tr\u00ean b\u1ec1 m\u1eb7t t\u1ebf b\u00e0o, k\u00edch ho\u1ea1t ho\u1ea1t t\u00ednh kinase n\u1ed9i t\u1ea1i, K\u00edch th\u00edch t\u00e1i t\u1ea1o bi\u1ec3u m\u00f4, l\u00e0m l\u00e0nh v\u1ebft th\u01b0\u01a1ng, duy tr\u00ec m\u00f4 kh\u1ecfe m\u1ea1nh, h\u00ecnh th\u00e0nh m\u1ea1ch m\u00e1u m\u1edbi. Nepidermin th\u01b0\u1eddng \u0111\u01b0\u1ee3c \u1ee9ng d\u1ee5ng trong \u0111i\u1ec1u tr\u1ecb v\u1ebft lo\u00e9t b\u00e0n ch\u00e2n do ti\u1ec3u \u0111\u01b0\u1eddng.<\/p>\n

\u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/h3>\n

Nepidermin phun tr\u1ef1c ti\u1ebfp tr\u00ean b\u1ec1 m\u1eb7t da, t\u1ef7 l\u1ec7 h\u1ea5p thu c\u00f2n h\u1ea1n ch\u1ebf, do \u0111\u00f3 gi\u1ea3m thi\u1ec3u t\u00e1c d\u1ee5ng ph\u1ee5 to\u00e0n th\u00e2n. Do \u0111\u00f3, d\u1eef li\u1ec7u d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc c\u1ee7a Nepidermin c\u00f2n h\u1ea1n ch\u1ebf.<\/p>\n

Thu\u1ed1c Easyef 0.5 mg\/ml \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/h2>\n

Thu\u1ed1c Easyef <\/strong>0.5 mg\/ml \u0111i\u1ec1u tr\u1ecb v\u1ebft lo\u00e9t b\u00e0n ch\u00e2n \u1edf b\u1ec7nh nh\u00e2n tr\u01b0\u1edfng th\u00e0nh b\u1ecb \u0111\u00e1i th\u00e1o \u0111\u01b0\u1eddng.<\/p>\n

\"Thu\u1ed1c
Thu\u1ed1c Easyef 0.5 mg\/ml \u0111i\u1ec1u tr\u1ecb lo\u00e9t b\u00e0n ch\u00e2n do \u0111\u00e1i th\u00e1o \u0111\u01b0\u1eddng<\/figcaption><\/figure>\n

Li\u1ec1u d\u00f9ng c\u1ee7a thu\u1ed1c Easyef 0.5 mg\/ml<\/h2>\n